[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100399901":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":34,"responsibleParty":124,"collaborators":126,"id":137,"slug":138,"hasResults":139,"nctId":140,"briefTitle":141,"officialTitle":142,"acronym":143,"eligibilityCriteria":144,"healthyVolunteers":139,"sex":145,"minAge":146,"maxAge":147,"enrollmentInfo":148,"targetDuration":18,"studyType":151,"phases":152,"briefSummary":154,"conditions":155,"keywords":157,"overallStatus":37,"whyStopped":18,"lastUpdateSubmitDate":158,"lastUpdatePostDateStruct":159,"startDateStruct":162,"completionDateStruct":164,"leadSponsor":166,"locationsCount":167},{"fullName":5,"class":6},"Southern California College of Optometry at Marshall B. Ketchum University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Vision Therapy","EXPERIMENTAL","Participants will receive 20 consecutive weeks of office-based vision therapy with home therapy.",[13],"Other: Vision Therapy",{"label":15,"type":16,"description":17,"interventionNames":18},"Observation","NO_INTERVENTION","Participants will receive no treatment for IXT is received during the study unless one of the deterioration criteria is met.",null,[20],{"type":6,"name":9,"description":21,"armGroupLabels":22,"otherNames":23},"20 consecutive weeks of office-based vision therapy with home therapy that aim to improve the participant's vergence skills, accommodative skills, and sensory fusion.",[9],[24],"Orthoptics",[26],{"name":27,"affiliation":5,"role":28},"Angela Chen, OD, MS","STUDY_CHAIR",[30],{"name":27,"role":31,"phone":32,"phoneExt":18,"email":33},"CONTACT","714-463-7569","angelachen@ketchum.edu",[35,54,65,79,94,109],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"University of Alabama in Birmingham","RECRUITING","Birmingham","Alabama","35294","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-86.80249,33.52066,{"lat":47,"lon":46},[50],{"name":51,"role":31,"phone":52,"phoneExt":18,"email":53},"Kristine Hopkins, OD, MSPH","205-996-1678","kbhopkins@uab.edu",{"facility":5,"status":37,"city":55,"state":56,"zip":57,"country":41,"countryCode":42,"cosmosGeoPoint":58,"geoPoint":62,"contacts":63},"Fullerton","California","92831",{"type":44,"coordinates":59},[60,61],-117.92534,33.87029,{"lat":61,"lon":60},[64],{"name":27,"role":31,"phone":32,"phoneExt":18,"email":33},{"facility":66,"status":37,"city":67,"state":56,"zip":68,"country":41,"countryCode":42,"cosmosGeoPoint":69,"geoPoint":73,"contacts":74},"Stanford University","Stanford","94305",{"type":44,"coordinates":70},[71,72],-122.16608,37.42411,{"lat":72,"lon":71},[75],{"name":76,"role":31,"phone":77,"phoneExt":18,"email":78},"Tawna Roberts, OD, PhD","650-723-1143","tawnar@stanford.edu",{"facility":80,"status":37,"city":81,"state":82,"zip":83,"country":41,"countryCode":42,"cosmosGeoPoint":84,"geoPoint":88,"contacts":89},"Ohio State University","Columbus","Ohio","43210",{"type":44,"coordinates":85},[86,87],-82.99879,39.96118,{"lat":87,"lon":86},[90],{"name":91,"role":31,"phone":92,"phoneExt":18,"email":93},"Ann Morrison, OD, MS","614-247-0010","morrison.421@osu.edu",{"facility":95,"status":37,"city":96,"state":97,"zip":98,"country":41,"countryCode":42,"cosmosGeoPoint":99,"geoPoint":103,"contacts":104},"Salus University","Philadelphia","Pennsylvania","19141",{"type":44,"coordinates":100},[101,102],-75.16362,39.95238,{"lat":102,"lon":101},[105],{"name":106,"role":31,"phone":107,"phoneExt":18,"email":108},"Erin Jenewein, OD, MS","215-276-6053","ejenewein@salus.edu",{"facility":110,"status":37,"city":111,"state":112,"zip":113,"country":41,"countryCode":42,"cosmosGeoPoint":114,"geoPoint":118,"contacts":119},"Southern College of Optometry","Memphis","Tennessee","38104",{"type":44,"coordinates":115},[116,117],-90.04898,35.14953,{"lat":117,"lon":116},[120],{"name":121,"role":31,"phone":122,"phoneExt":18,"email":123},"Marie Bodack, OD","901-722-3349","mbodack@sco.edu",{"type":125,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[127,128,129,130,132,133,135],{"name":66,"class":6},{"name":80,"class":6},{"name":95,"class":6},{"name":131,"class":6},"University of Alabama at Birmingham",{"name":110,"class":6},{"name":134,"class":6},"Case Western Reserve University",{"name":136,"class":6},"American Academy of Optometry","100399901","trial-of-vision-therapy-for-intermittent-exotropia-100399901",false,"NCT04487249","Trial of Vision Therapy for Intermittent Exotropia","A Pilot Randomized Trial Evaluating Short-Term Effectiveness of Vision Therapy in Children With Intermittent Exotropia","VT-IXT","Major Inclusion Criteria-\n\n* Age 8 - 16 years\n* Intermittent exotropia meeting all of the following:\n\n  * Distance exodeviation of 15∆ to 35∆ by prism alternating cover test (PACT)\n  * IXT, exophoria, or orthophoria at near\n  * Near exodeviation that does not exceed the distance exodeviation by more than 10∆\n  * Mean distance control score of 2 points or more with at least one measure being 3 points or higher\n  * Mean near control score less than 5 points\n* Random dot stereopsis of 200\" or better on Preschool Randot Stereotest\n* Willingness to accept randomization and no plan to relocate in the next 6 months\n\nMajor Exclusion Criteria-\n\n* Treatment for IXT or amblyopia (other than refractive correction) within 3 months prior to enrollment\n* Office-based vision therapy for IXT within 6 months prior to enrollment\n* Prior office-based vision therapy for IXT of ≥10 sessions\n* Prior strabismus, intraocular, or refractive surgery (including BOTOX injection)","ALL","8 Years","16 Years",{"count":149,"type":150},58,"ESTIMATED","INTERVENTIONAL",[153],"NA","The main objective of this randomized trial comparing vision therapy to observation is to determine the short-term effectiveness of vision therapy on distance intermittent exotropia control. The results will help determine whether to proceed to a full-scale, long-term randomized trial.",[156],"Intermittent Exotropia",[156,9],"2025-03-04",{"date":160,"type":161},"2025-03-05","ACTUAL",{"date":163,"type":161},"2021-10-01",{"date":165,"type":150},"2025-12",{"name":5,"class":6},6]